ProCE Banner Series

APPlexus Hematology: Clinic-Ready Insights from the Top Abstracts Presented at the 2023 Annual Hematology Meeting

APPlexus Hematology is an initiative designed to address educational needs specific to APPs who care for patients with malignant or nonmalignant hematologic disorders. These webinars will navigate the profound insights from the 2023 ASH Annual Meeting (#ASH23) and will deliver innovative, real-time education to NPs and PAs worldwide. Our mission is to bridge knowledge gaps, untangle controversies, and spotlight pivotal abstracts from #ASH23 in a digestible and engaging format.

  AAPA
  | ANCC
Who Should Attend

This program is intended for NPs, PAs, and other healthcare professionals who care for patients with malignant or nonmalignant hematologic disorders.

All Events

APPlexus Hematology: Clinic-Ready Insights from the Top Abstracts Presented at the 2023 Annual Hematology Meeting

Past Events

February

03

2024

8:00 AM - 1:20 PM Eastern Time (ET)

Virtual

February

10

2024

8:00 AM - 1:20 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Catherine M. Broome, MD

Professor of Medicine
Division of Hematology/Oncology
MedStar Georgetown University Hospital
Washington, DC

ProCE Banner Faculty
Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, Ohio

ProCE Banner Faculty
Charise Gleason, MSN, NP-C, AOCNP

VP and Chief APP Officer
Emory Healthcare
NP Myeloma Program Winship Cancer Institute
Adjunct Faculty
Nell Hodgson Woodruff School of Nursing
Atlanta, Georgia

ProCE Banner Faculty
Amy Goodrich, MSN-CRNP-AC

Nurse Practitioner
Johns Hopkins School of Medicine
Johns Hopkins Kimmel Cancer Center
Baltimore, Maryland

ProCE Banner Faculty
Kathryn Johnson, DNP, MSc, FNP-BC,

Clinical Program Manager
Adult Leukemia & Myelofproliferative Neoplasms
Clinical Trials Program
Icahn School of Medicine at Mount Sinai
New York, New York

ProCE Banner Faculty
Cyrus Khan, MD

Director of Marrow Collection Facility Cell Transplant Program
Hematology Oncology
Western Pennsylvania Hospital
Pittsburgh, Pennsylvania

ProCE Banner Faculty
Christopher Nelson, MSN, ACNP-BC, MBA

Acute Care Nurse Practitioner
Oncology Avera Cancer Institute
Sioux Falls, SD

ProCE Banner Faculty
Lisa Nodzon, PhD, APRN, AOCNP

Moffitt Cancer Center
Department of Malignant Hematology
Tampa, Florida

ProCE Banner Faculty
Linda Perry, MS, PA-C

Physician Assistant
Hematology
University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania

ProCE Banner Faculty
Mary Steinbach, APRN

Nurse Practitioner
Blood and Marrow Transplant; Hematology; Multiple Myeloma
University of Utah Huntsman Cancer Institute
Salt Lake City, Utah

ProCE Banner Faculty
Eunice S. Wang, MD

Chief, Leukemia/Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Topics

February 3, 2024

Leukemias

Lymphoma I

Lymphoma II

 

February 10, 2024

Multiple Myeloma

Myeloproliferative neoplasms (MPNs)

Non-Malignant Hematology

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
To improve the knowledge, confidence, and skills of NPs/PAs who care for patients with malignant or nonmalignant hematologic disorders regarding the latest updates in guideline-directed evidence-based medicine, therapeutic management, and strategies to improve health equity, ultimately improving clinical outcomes for their patients. 

Target Audience
This program is intended for NPs, PAs, and other healthcare professionals who care for patients with malignant or nonmalignant hematologic disorders. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate recent clinical data to tailor and enhance treatment strategies for patients diagnosed with malignant or nonmalignant hematologic conditions.
  • Assess the implications and potential of emerging agents and therapeutic innovations in managing patients with malignant or nonmalignant hematologic disorders.
  • Evaluate the potential impact of contemporary trial outcomes on shaping future treatment paradigms for patients with malignant or nonmalignant hematologic disorders.

Accreditation

See event registration page for accreditation information.

Acknowledgement

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC

Supported by an educational grant from AbbVie Inc.